Cutler Group LP Co Diagnostics, Inc. Call Options Transaction History

Cutler Group LP

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Oct 25, 2022	SELL	$2.87 - $7.01 $6,888 - $16,824	-2,400 Reduced 92.31%	200 $0
Q2 2022 Aug 04, 2022	BUY	$3.76 - $6.29 $5,264 - $8,806	1,400 Added 116.67%	2,600 $0
Q1 2022 Apr 14, 2022	SELL	$5.03 - $9.61 $1,509 - $2,883	-300 Reduced 20.0%	1,200 $0
Q4 2021 Jan 18, 2022	BUY	$8.12 - $10.37 $7,307 - $9,333	900 Added 150.0%	1,500 $0
Q3 2021 Oct 26, 2021	SELL	$7.48 - $11.38 $4,488 - $6,828	-600 Reduced 50.0%	600 $0
Q2 2021 Jul 19, 2021	SELL	$7.16 - $9.56 $12,172 - $16,252	-1,700 Reduced 58.62%	1,200 $0
Q1 2021 Apr 26, 2021	SELL	$8.52 - $19.21 $24,708 - $55,709	-2,900 Reduced 50.0%	2,900 $2,000
Q4 2020 Jan 21, 2021	SELL	$9.3 - $15.19 $282,720 - $461,776	-30,400 Reduced 83.98%	5,800 $1,000
Q3 2020 Oct 27, 2020	BUY	$8.24 - $30.8 $79,928 - $298,760	9,700 Added 36.6%	36,200 $42,000
Q2 2020 Jul 22, 2020	SELL	$7.46 - $23.42 $155,168 - $487,136	-20,800 Reduced 43.97%	26,500 $126,000
Q1 2020 May 07, 2020	BUY	$0.91 - $17.81 $43,043 - $842,412	47,300 New	47,300 $47,000

4.3M

48.2K

53.3K

Ticker CODX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,781,000
Market Cap $35.8M
Description
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.